IndicationsStatusPurposePhase
CompletedDiagnostic2
clinicaltrials.gov IdentifierTitleDrugs
NCT00425854An Open Label Phase II Trial of BIBW 2992 in Patients With HER2-negative Metastatic Breast Cancer